A quantitative systems pharmacology framework of immunogenicity to propose mitigation strategies after subcutaneous administrationOral presentation, GMP Symposium 2024 Selvaggio G, Pellowe M, Chenel M, Sjögren E.ConferenceMethodologySpecial considerationsPharmetheus Affiliates Director, MIDD ConsultantGianluca SelvaggioSee bio Director, MIDD ConsultantMoriah PelloweSee bio Chief Research OfficerMarylore ChenelSee bio Principal Director, PBPK & PBBM Scientific LeadErik SjögrenSee bio